BioSpace News Archive

Voluntis (Euronext Paris, Ticker: VTX - ISIN: FR0004183960) (Paris:VTX), a company specializing in digital therapeutics, announces Roche Pharma France’s decision to end the agreement, announced in March 2018, to extend the ZEMY solution, initially developed in breast cancer, to all solid tumors.

Astronomer, creator of the leading managed Apache Airflow platform, announced today that it has successfully completed the spin-off of its streaming data routing (“Clickstream”) division into the newly created MetaRouter,

Right now, our primary concern is for the health and safety of our children and their families, our staff, and other residents

The OpenSight® Augmented Reality System is the first AR medical solution for Microsoft HoloLens cleared by the FDA receiving 510(k) clearance for use in pre-operative surgical planning.

At a time when primary care physicians are increasingly disgruntled about their work environment and physician burnout reaches an all-time high, the physicians at Central Ohio Primary Care (COPC) are more satisfied and loyal than customers of some of the nation’s most beloved corporations.

The Medical Affairs Professional Society (MAPS), the premier non-profit global society of Medical Affairs professionals, is pleased to announce the launch of the Medical Affairs Strategic Planning Guide and Template

Jennifer Kingsley Wilson, CEO of ARMSRx, one of the nation’s premiere Pharmacy Benefit Consulting firms, will co-present with Orlando Health’s Human Resources Corporate Director of Total Rewards, Joy Sylvester, at the HEALTHCARE REVOLUTION® conference on Tuesday, October 30th at 10:00 am in Room 304 G at the Orange County Convention Center Orlando, Florida.

Variant Pharmaceuticals (Variant), a clinical stage orphan drug company developing first-in-class drugs for patients with rare diseases, announced today publication of preclinical data evaluating 2HPβCD in experimental models of Alport Syndrome and FSGS.

Intelligent Retinal Imaging Systems (IRIS) announced today that its cloud-based diagnostic imaging solution and retinal telemedicine platform has now identified over 50,000 patients with advanced sight-threatening pathologies that would have led to imminent blindness had they remained undetected

The art and science of eye care on display during the 122nd annual meeting of the American Academy of Ophthalmology